Abstract
Abstract
Certain matrix metalloproteinases (MMPs) have the ability to degrade collagen IV, a main component of the breast lobular basement membrane. In this cross-sectional study, we evaluated expression of MMPs 2, 9, and 14 and collagen IV in LCIS and adjacent normal breast tissue among LCIS patients without invasive breast cancer to determine whether expression differed between benign and preinvasive breast epithelial tissue. A total of 64 LCIS patients, diagnosed 2004–2014, were included; 44 had sufficient paired normal tissue for analysis. Marker epithelial expression was measured using immunofluorescence and quantified using the H score (MMPs) or pixel intensity (collagen IV). Associations were evaluated using the Spearman correlation or the Wilcoxon signed-rank test. In LCIS and normal tissue, there was a strong correlation between MMP2 and MMP14 expression (LCIS r = 0.69, normal r = 0.81, both P < 0.01). Other pairwise correlations were moderate to weak (range: LCIS r = 0.32–0.47, normal r = 0.19–0.32). For all markers, expression was lower in LCIS vs. normal tissue (all P ≤ 0.05). In sum, collagenase MMPs were expressed in normal breast and LCIS lesions of LCIS patients. However, expression was not higher in LCIS compared with normal tissue, suggesting collagenase MMP expression does not increase as breast tissue gains a more proliferative phenotype.
Funder
University of North Carolina at Chapel Hill Department of Radiology
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Morrow, M., Schnitt, S. J. & Norton, L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol 12, 227–238 (2015).
2. Howlader, N. et al. SEER cancer statistics review, 1975–2013, National Cancer Institute, Bethesda, MD. Available from:
http://seer.cancer.gov/csr/1975_2013/
, based on November 2015 SEER data submission, posted April 2016.
3. Ward, E. M. et al. Cancer statistics: Breast cancer in situ. CA Cancer J Clin 65, 481–495 (2015).
4. Logan, G. J. et al. Molecular drivers of lobular carcinoma in situ. Breast Cancer Res 17, 76 (2015).
5. Afonso, N. & Bouwman, D. Lobular carcinoma in situ. Eur J Cancer Prev 17, 312–316 (2008).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献